SPRO - Spero Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts5566
Avg. Estimate-0.65-0.9-3.05-3.56
Low Estimate-0.98-1.06-3.65-4.11
High Estimate0.19-0.77-2.12-3.21
Year Ago EPS-0.69-0.6-2.6-3.05
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts5556
Avg. Estimate5.05M1.71M15.53M8.38M
Low EstimateN/AN/A7.72MN/A
High Estimate17.4M4.4M25.92M17.5M
Year Ago Sales463kN/A3.97M15.53M
Sales Growth (year/est)990.70%N/A291.60%-46.00%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.78-0.63-0.75-0.78
EPS Actual-0.69-0.6-0.6-0.29
Difference0.090.030.150.49
Surprise %11.50%4.80%20.00%62.80%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.65-0.9-3.05-3.56
7 Days Ago-0.65-0.9-3.05-3.56
30 Days Ago-0.59-0.93-3.07-3.56
60 Days Ago-0.63-1-3.6-3.56
90 Days Ago-0.63-1-3.48-3.59
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesSPROIndustrySectorS&P 500
Current Qtr.5.80%N/AN/A0.01
Next Qtr.-50.00%N/AN/A0.03
Current Year-17.30%N/AN/A0.04
Next Year-16.70%N/AN/A0.10
Next 5 Years (per annum)24.00%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A